US20110243847A1 - Imaging diagnostics by combining contrast agents - Google Patents

Imaging diagnostics by combining contrast agents Download PDF

Info

Publication number
US20110243847A1
US20110243847A1 US12/666,205 US66620508A US2011243847A1 US 20110243847 A1 US20110243847 A1 US 20110243847A1 US 66620508 A US66620508 A US 66620508A US 2011243847 A1 US2011243847 A1 US 2011243847A1
Authority
US
United States
Prior art keywords
eccm
lscm
contrast agent
imaging
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/666,205
Other languages
English (en)
Inventor
Ulrike Wiebelitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MIVENION GmbH
Original Assignee
MIVENION GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38627016&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110243847(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by MIVENION GmbH filed Critical MIVENION GmbH
Assigned to MIVENION GMBH reassignment MIVENION GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WIEBELITZ, ULRIKE
Publication of US20110243847A1 publication Critical patent/US20110243847A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/48—Diagnostic techniques
    • A61B6/481—Diagnostic techniques involving the use of contrast agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A61K49/105—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA the metal complex being Gd-DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus for radiation diagnosis, e.g. combined with radiation therapy equipment
    • A61B6/02—Devices for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computerised tomographs
    • A61B6/037—Emission tomography

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Pathology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
US12/666,205 2007-06-22 2008-06-20 Imaging diagnostics by combining contrast agents Abandoned US20110243847A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07110922A EP2005970A1 (fr) 2007-06-22 2007-06-22 Imagerie Diagnostique par combinaison de moyens de contraste
EP07110922.7 2007-06-22
PCT/EP2008/057886 WO2009000777A2 (fr) 2007-06-22 2008-06-20 Diagnostics d'imagerie par combinaison d'agents de contraste

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/057886 A-371-Of-International WO2009000777A2 (fr) 2007-06-22 2008-06-20 Diagnostics d'imagerie par combinaison d'agents de contraste

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/860,675 Division US9179882B2 (en) 2007-06-22 2013-04-11 Imaging diagnostics by combining contrast agents

Publications (1)

Publication Number Publication Date
US20110243847A1 true US20110243847A1 (en) 2011-10-06

Family

ID=38627016

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/666,205 Abandoned US20110243847A1 (en) 2007-06-22 2008-06-20 Imaging diagnostics by combining contrast agents
US13/860,675 Active US9179882B2 (en) 2007-06-22 2013-04-11 Imaging diagnostics by combining contrast agents
US14/859,595 Active 2028-09-27 US9682159B2 (en) 2007-06-22 2015-09-21 Imaging diagnostics by combining contrast agents

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/860,675 Active US9179882B2 (en) 2007-06-22 2013-04-11 Imaging diagnostics by combining contrast agents
US14/859,595 Active 2028-09-27 US9682159B2 (en) 2007-06-22 2015-09-21 Imaging diagnostics by combining contrast agents

Country Status (10)

Country Link
US (3) US20110243847A1 (fr)
EP (6) EP2005970A1 (fr)
CY (1) CY1116213T1 (fr)
DK (2) DK2572735T3 (fr)
ES (2) ES2534970T3 (fr)
HR (1) HRP20150472T1 (fr)
PL (2) PL2170405T3 (fr)
PT (1) PT2572735E (fr)
SI (2) SI2170405T1 (fr)
WO (1) WO2009000777A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10032268B2 (en) 2012-08-06 2018-07-24 Koninklijke Philips N.V. Dynamic contrast-enhanced imaging based permeability metric
WO2020243585A1 (fr) * 2019-05-29 2020-12-03 Sicreations, Llc Procédés de conservation d'un sujet et utilisation d'agents de contraste d'imagerie
US11054534B1 (en) 2020-04-24 2021-07-06 Ronald Nutt Time-resolved positron emission tomography encoder system for producing real-time, high resolution, three dimensional positron emission tomographic image without the necessity of performing image reconstruction
US11300695B2 (en) 2020-04-24 2022-04-12 Ronald Nutt Time-resolved positron emission tomography encoder system for producing event-by-event, real-time, high resolution, three-dimensional positron emission tomographic image without the necessity of performing image reconstruction
CN115785468A (zh) * 2022-11-21 2023-03-14 苏州大学 一种用于富集细胞外囊泡的zif-8-dspe材料及其制备方法和应用
US11730831B2 (en) 2019-03-26 2023-08-22 Sicreations, Llc Imaging agents and methods of using the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2706373C1 (ru) * 2019-03-01 2019-11-18 Федеральное Государственное бюджетное образовательное учреждение высшего образования Дагестанский государственный медицинский университет Министерства здравоохранения Российской Федерации Способ определения локализации опухолевой обструкции билиарного тракта и степени её распространенности

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059415A (en) * 1989-02-21 1991-10-22 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon Health Method for diagnostically imaging lesions in the brain inside a blood-brain barrier
US20020061279A1 (en) * 2000-04-28 2002-05-23 Degrado Timothy R. 18F-labeled choline analogs
US6490476B1 (en) * 1999-10-14 2002-12-03 Cti Pet Systems, Inc. Combined PET and X-ray CT tomograph and method for using same
US6972122B2 (en) * 2001-01-05 2005-12-06 Duke University Contrast enhancement agent for magnetic resonance imaging
US20080008366A1 (en) * 2006-06-20 2008-01-10 Vladimir Desh Simultaneous visualization, analysis and navigation of multi-modality medical imaging data

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4444690A (en) 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4673562A (en) 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4670545A (en) 1984-05-11 1987-06-02 University Patents, Inc. Chelating agents for technetium-99M
US4980147A (en) 1984-06-25 1990-12-25 University Of Utah Research Foundation Radiolabeled technetium chelates for use in renal function determinations
US4897255A (en) 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US4965392A (en) 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5198208A (en) 1987-07-16 1993-03-30 Nycomed Imaging As Aminopolycarboxylic acids and derivatives thereof
US5021556A (en) 1987-07-22 1991-06-04 Neorx Corporation Method of radiolabeling chelating compounds comprising sulfur atoms with metal radionuclides
GB8808305D0 (en) 1988-04-08 1988-05-11 Nycomed As Compositions
US4988496A (en) 1988-05-31 1991-01-29 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5075099A (en) 1988-05-31 1991-12-24 Neorx Corporation Metal radionuclide chelating compounds for improved chelation kinetics
US5364613A (en) 1989-04-07 1994-11-15 Sieving Paul F Polychelants containing macrocyclic chelant moieties
US5078985A (en) 1989-08-09 1992-01-07 Rhomed, Incorporated Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction
JPH03228046A (ja) 1989-09-13 1991-10-09 Konica Corp 赤外吸収染料を有し経時安定性に優れる写真材料
US5367080A (en) 1990-11-08 1994-11-22 Sterling Winthrop Inc. Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods
EP0664713B1 (fr) 1992-10-14 2000-01-19 Nycomed Imaging As Procedes et compositions d'imagerie diagnostique et therapeutique
US5756688A (en) 1992-10-14 1998-05-26 Sterling Winthrop Inc. MR imaging compositions and methods
JPH08502528A (ja) 1992-10-14 1996-03-19 スターリング ウィンスロップ アイエヌシー． キレート化ポリマー
CA2150477A1 (fr) 1992-11-30 1994-06-09 Robert Allen Snow Ciblage sequentiel des sites tumoraux a l'aide de conjugues oligonucleotidiques d'anticorps et de conjugues oligonucleotidiques complementaires de radionucleides chelates
JPH08507750A (ja) 1992-12-15 1996-08-20 ザ・ウエルカム・ファウンデーション・リミテッド ジヒドロフォレートレダクターゼを用いる免疫反応試薬
US5559214A (en) 1993-05-28 1996-09-24 Sterling Winthrop Inc. Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods
AU7244894A (en) 1993-06-07 1995-01-03 Wellcome Foundation Limited, The Immunoreactive reagents employing monoamine oxidase
DE4326466A1 (de) 1993-08-06 1995-02-09 Boehringer Mannheim Gmbh Infrarot-Farbstoff-markierte Nucleotide und ihre Verwendung in der Nucleinsäure-Detektion
US5730968A (en) 1994-03-31 1998-03-24 Sterling Winthrop Inc. Segmented chelating polymers as imaging and therapeutic agents
DE4445065A1 (de) 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
US5591217A (en) 1995-01-04 1997-01-07 Plexus, Inc. Implantable stimulator with replenishable, high value capacitive power source and method therefor
AU4497096A (en) 1995-01-30 1996-08-21 Daiichi Pure Chemicals Co., Ltd. Diagnostic marker
IL125748A (en) 1996-02-19 2002-05-23 Nycomed Imaging As Contrast-containing gases for use in diagnostic imaging
US6628982B1 (en) 2000-03-30 2003-09-30 The Regents Of The University Of Michigan Internal marker device for identification of biological substances
US7286867B2 (en) 2003-10-16 2007-10-23 Brookhaven Science Associates, Llc Combined PET/MRI scanner
WO2007008232A2 (fr) * 2004-09-03 2007-01-18 Board Of Regents, The University Of Texas System Ablation locoregionale interne de tissus anormaux par des radionucleides
GB0422004D0 (en) 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
HUE038724T2 (hu) 2004-11-24 2018-11-28 Bayer Healthcare Llc Eszközök és összeállítások fluidumbejuttatáshoz
EP1853161A4 (fr) 2004-12-29 2011-03-23 Siemens Medical Solutions Systeme d'imagerie par tep/rm combine et detecteur tep base sur une photodiode a avalanche utilises en imagerie simultanee tep/rm
WO2006078817A2 (fr) 2005-01-21 2006-07-27 Medrad, Inc. Injecteurs, systemes d'injecteur et procedes d'injection de liquides
EP1888145A1 (fr) 2005-05-16 2008-02-20 Mallinckrodt Inc. Seringue a cylindres multiples possedant un collecteur integre
DE102005023906B4 (de) 2005-05-24 2013-01-31 Siemens Aktiengesellschaft Verfahren zur Ermittlung von Positronen-Emissions-Messinformationen im Rahmen der Positronen-Emissions-Tomographie
DE102005040107B3 (de) 2005-08-24 2007-05-31 Siemens Ag Kombiniertes PET-MRT-Gerät und Verfahren zur gleichzeitigen Aufnahme von PET-Bildern und MR-Bildern
DE102005045600B4 (de) 2005-09-23 2008-01-17 Siemens Ag Injektor und Verfahren zum Unterstützen der Bildgebung an einem Patienten
US20080146914A1 (en) * 2006-12-19 2008-06-19 General Electric Company System, method and apparatus for cancer imaging

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059415A (en) * 1989-02-21 1991-10-22 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon Health Method for diagnostically imaging lesions in the brain inside a blood-brain barrier
US6490476B1 (en) * 1999-10-14 2002-12-03 Cti Pet Systems, Inc. Combined PET and X-ray CT tomograph and method for using same
US20020061279A1 (en) * 2000-04-28 2002-05-23 Degrado Timothy R. 18F-labeled choline analogs
US6972122B2 (en) * 2001-01-05 2005-12-06 Duke University Contrast enhancement agent for magnetic resonance imaging
US20080008366A1 (en) * 2006-06-20 2008-01-10 Vladimir Desh Simultaneous visualization, analysis and navigation of multi-modality medical imaging data

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Andrei Iagaru et al., Breast MRI and 18F FDG TET/CT in the management of breast cancer, Annals of Nuclear Medicine Vol 21(1), 33-38, 2007. *
B.M. Gallagher et al., Radiopharmaceuticals XXVII. 18F-Labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regiional myocardial glucose metabolism in vivo: Tissue distribution and imaging studies in animals, J. Nucl. Med. 18, 990-996, 1977. *
Yuka Yamamot et al. 3'-Deoxy-3'-[F-18]Fluorothymidine Positron Emission Tomography in Patients with Recurrent Glioblastoma Multiforme:Comparison with Gd-DPTA Enhanced Magnetic Resonance Imaging, Mol. Imaging Biol. 2006, B:340-347. *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10032268B2 (en) 2012-08-06 2018-07-24 Koninklijke Philips N.V. Dynamic contrast-enhanced imaging based permeability metric
US11730831B2 (en) 2019-03-26 2023-08-22 Sicreations, Llc Imaging agents and methods of using the same
WO2020243585A1 (fr) * 2019-05-29 2020-12-03 Sicreations, Llc Procédés de conservation d'un sujet et utilisation d'agents de contraste d'imagerie
US11833227B2 (en) 2019-05-29 2023-12-05 Sicreations, Llc Methods for preserving a subject and using imaging contrast agents
US11054534B1 (en) 2020-04-24 2021-07-06 Ronald Nutt Time-resolved positron emission tomography encoder system for producing real-time, high resolution, three dimensional positron emission tomographic image without the necessity of performing image reconstruction
US11300695B2 (en) 2020-04-24 2022-04-12 Ronald Nutt Time-resolved positron emission tomography encoder system for producing event-by-event, real-time, high resolution, three-dimensional positron emission tomographic image without the necessity of performing image reconstruction
CN115785468A (zh) * 2022-11-21 2023-03-14 苏州大学 一种用于富集细胞外囊泡的zif-8-dspe材料及其制备方法和应用

Also Published As

Publication number Publication date
CY1116213T1 (el) 2017-03-15
US9682159B2 (en) 2017-06-20
PL2572735T3 (pl) 2015-07-31
WO2009000777A2 (fr) 2008-12-31
EP2514442A2 (fr) 2012-10-24
EP2572735A1 (fr) 2013-03-27
EP2647392A2 (fr) 2013-10-09
PL2170405T3 (pl) 2013-06-28
SI2170405T1 (sl) 2013-01-31
US9179882B2 (en) 2015-11-10
EP2514442A3 (fr) 2013-03-20
US20130224113A1 (en) 2013-08-29
DK2170405T3 (da) 2013-01-07
DK2572735T3 (en) 2015-03-30
EP2647392A3 (fr) 2014-01-08
EP2572735B1 (fr) 2015-02-25
US20160008496A1 (en) 2016-01-14
ES2534970T3 (es) 2015-04-30
EP2005970A1 (fr) 2008-12-24
ES2395436T3 (es) 2013-02-12
EP2907526A1 (fr) 2015-08-19
HRP20150472T1 (en) 2015-06-05
WO2009000777A3 (fr) 2009-08-13
PT2572735E (pt) 2015-05-18
WO2009000777A4 (fr) 2009-10-01
EP2170405A2 (fr) 2010-04-07
EP2170405B1 (fr) 2012-09-12
SI2572735T1 (sl) 2015-05-29

Similar Documents

Publication Publication Date Title
US9682159B2 (en) Imaging diagnostics by combining contrast agents
Sharma et al. New horizons for imaging lymphatic function
Blum et al. Preoperative CT and MR imaging of inferior vena cava leiomyosarcoma
Müller et al. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver
JP2003500136A5 (fr)
HU225522B1 (en) Use of intravenous contrast agents and devices for projection mammography
Chen et al. Scope of diagnostic imaging
Murdoch-Kinch Salivary gland imaging
Henes et al. Intraindividual comparison of gadolinium-and iodine-enhanced 64-slice multidetector CT pulmonary angiography for the detection of pulmonary embolism in a porcine model
EP3714905A1 (fr) Préparation pour un diagnostic par résonance magnétique de maladies oncologiques contenant du 3-o-méthylglucose deutéré et méthode de diagnostic utilisant ce produit
US5807536A (en) Anatomical imaging with phycocyanins
US20040175329A1 (en) Method for continuous visualization of a body lumen
WO2006052292A1 (fr) Procede de visualisation continue d'un caillot sanguin ou d'une plaque dans une lumiere corporelle
Zafeirakis et al. Non-invasive Radiological Modalities for the Evaluation of Neuroendocrine Liver Tumors
Lv et al. Liquid Metal Biomedical Imaging
Albelda et al. Imaging atoms in medicine
Yang et al. Cone beam CT tumor vasculature dynamic study (Murine model)
Wietholt et al. Comparison of CT contrast blood pool agents for in-vivo 3D angiography using microCT
Enzweiler et al. Contrast Enhancement in Electron Beam Tomography of the Heart: Comparison of a Monomeric and a Dimeric Iodinated Contrast Agent in 59 Patients1
Shim et al. Oncologic Imaging
Renda et al. Diagnostic imaging techniques for synchronous multiple tumors
Choon et al. Imaging hepatocellular carcinoma
Chi et al. Conventional angiography, CTA, and MRA of the mesenteric arteries
AlObaidy et al. Basic principles of radiologic modalities
Jager Tumor imaging using L-3-[123I] iodo-alpha-methyl-tyrosine

Legal Events

Date Code Title Description
AS Assignment

Owner name: MIVENION GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WIEBELITZ, ULRIKE;REEL/FRAME:024646/0292

Effective date: 20100701

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION